The design of clinical trials in hepatocellular carcinoma (HCC) is complex because many patients have concurrent liver disease, which can confound the assessment of clinical benefit. There is an urgent need for high-quality trials in this disease. An expert panel was convened by the American Associa...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!